Atlas Trials

Open-Label Study of the Long Term Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Clinical trial NCT00662038 · COMPLETED

Trial details

NCT number
NCT00662038
Sponsor
Genentech, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Idiopathic Pulmonary Fibrosis
Start date
2008-08-01
Primary completion
2016-02-01
Enrollment
1058

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.